Remifentanil and eye movement disorder Patient Reports February 13, 2012

Remifentanil Side Effects Report #5015676-8
Remifentanil side effect was reported by a Consumer or non-health professional from ARGENTINA on May 17, 2006. Female patient, 66 years of age, was treated with Remifentanil. After drug was administered, patient experienced the following side effects: agitation, coma, eye movement disorder, hyperhidrosis, hyperreflexia, hypertonia, intentional overdose, muscle rigidity. Remifentanil dosage: unknown. During the same period patient was treated with TRANYLCYPROMINE, TRIFLUOPERAZINE HYDROCHLORIDE, LORAZEPAM, FLUOXETINE, MIDAZOLAM, PANCURONIUM BROMIDE. Patient was hospitalized. Patient recovered.